Dr Reddy's Laboratories Ltd
DRREDDY.NS · Health Technology · Pharmaceuticals: Major · IN
21,650 employees · drreddys.com
About
Dr Reddy's Laboratories Ltd generates revenue through its three business segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment sells branded formulations and generic finished dosages under brand names, targeting healthcare providers and patients. PSAI supplies active pharmaceutical ingredients and intermediates to other manufacturers. Proprietary Products, marketed via subsidiary Promius Pharma, LLC, focuses on dermatology and neurology treatments developed through research and development. The company's products include prescription and over-the-counter finished pharmaceuticals, active pharmaceutical ingredients, and differentiated formulations. Brands such as Promius Pharma, LLC are used for proprietary products, while generic products are sold under therapeutic equivalence to branded formulations. Healthcare providers and patients purchase Global Generics products, while other pharmaceutical companies buy PSAI ingredients for their own manufacturing processes. Dr Reddy's Laboratories employs 21,650 full-time employees to support its operations across all segments. The Global Generics segment handles manufacturing and marketing of ready-to-consume products, PSAI manages bulk drug production, and Proprietary Products drives innovation in dermatology and neurology through its subsidiary Promius Pharma, LLC.
Annual results
Reported figures, INR · revenue up 2.9% in 2026
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2026 | 336B | 42.9B | 12.8% | — |
| 2025 | 326B | 56.6B | 17.3% | — |
| 2024 | 280B | 55.8B | 19.9% | — |
| 2023 | 247B | 45.1B | 18.3% | — |
| 2022 | 215B | 21.8B | 10.1% | — |
Dividends per share
DRREDDY.NS in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Dr Reddy's Laboratories Ltd are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.